Samsung Acquires Medical Imaging Company – NeuroLogica

SamsungSamsung Electronics America, Inc., a subsidiary of Samsung Electronics Co. Ltd, today announced its acquisition of NeuroLogica, a leading Computed Tomography (CT) company headquartered in Danvers, Massachusetts.

Established in 2004, NeuroLogica develops cutting-edge medical imaging products and is known for its world-class portable CT scanners, such as BodyTom and CereTom. Terms of the deal were not disclosed.

"The acquisition of NeuroLogica is another important step in the expansion of Samsung's medical imaging business and is a testament to our shared vision for a better and more complete healthcare experience," said Tod Pike, senior vice president at Samsung's Enterprise Business Division. "We are committed to further strengthening our capabilities and products to help establish Samsung as a trusted leader in the health and medical equipment industry."

Samsung plans to leverage its global brand awareness and world-leading technology in consumer electronics, IT and communications with NeuroLogica in order to expand medical imaging business.

Samsung Electronics is committed to its 2020 vision to explore new avenues of growth in the healthcare business by enhancing medical imaging diagnosis, providing innovation to both patients and doctors.

To learn more about Samsung Electronics' healthcare division, its subsidiaries and products, please visit http://www.samsung.com/healthcare

 

 

About NeuroLogica

Located in Danvers, Massachusetts, NeuroLogica Corp (www.neurologica.com) specializes in the design and manufacture of cutting edge imaging equipment that is easy to use and brings the power of imaging to the patient. NeuroLogica's BodyTom® CT and CereTom® CT are FDA registered and the quality system is certified to ISO 13485:2003 and ISO 9001:2008 with Canadian Medical Device Amendments. NeuroLogica's BodyTom® CT and CereTom® CT are CE marked (European Conformity) for distribution in the European Union and European Economic Area.

 

 

 

Comments

Feed Feed You can follow this conversation by subscribing to the comment feed for this post.

Leave a comment

Your email address will not be published. Required fields are marked *

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>